Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Emory University Winship Cancer Institute, Atlanta, Georgia Norton Cancer Institute, Louisville, Kentucky Weill Cornell - NY Presbyterian Hospital, New York, New York China
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality Beijing Cancer Hospital, Beijing, Beijing Municipality